ENDRA Life Sciences Inc. (NDRA): Price and Financial Metrics
NDRA Price/Volume Stats
| Current price | $0.24 | 52-week high | $2.79 |
| Prev. close | $0.23 | 52-week low | $0.22 |
| Day low | $0.24 | Volume | 24,326 |
| Day high | $0.25 | Avg. volume | 169,238 |
| 50-day MA | $0.85 | Dividend yield | N/A |
| 200-day MA | $1.12 | Market Cap | 2.70M |
NDRA Stock Price Chart Interactive Chart >
ENDRA Life Sciences Inc. (NDRA) Company Bio
ENDRA Life Sciences Inc. operates as a biotechnology company. The Company develops a medical imaging technology based on the thermoacoustic effect that improves the sensitivity and specificity of clinical ultrasound. ENDRA Life Sciences serves customers worldwide.
Latest NDRA News From Around the Web
Below are the latest news stories about ENDRA LIFE SCIENCES INC that investors may wish to consider to help them evaluate NDRA as an investment opportunity.
ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System TechnologyANN ARBOR, Mich., November 29, 2023--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the United States Patent and Trademark Office has issued to ENDRA a new patent, U.S. Patent No. 11828727 (the ‘727 patent) titled "Thermoacoustic Probe." |
ENDRA Life Sciences to Participate in The Benchmark Company’s 12th Annual Discovery One-on-One Investor ConferenceANN ARBOR, Mich., November 27, 2023--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that management will be participating in The Benchmark Company’s 12th Annual Discovery One-on-One Investor Conference being held Thursday, December 7, 2023 at the New York Athletic Club in New York City. Management will be holding one-on-one meetings with investors. |
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q3 2023 Earnings Call TranscriptENDRA Life Sciences Inc. (NASDAQ:NDRA) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Good day, and welcome to the ENDRA Life Sciences Third Quarter 2023 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference […] |
ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business UpdateANN ARBOR, Mich., November 14, 2023--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reports financial results for the three and nine months ended September 30, 2023 and provides a business update. Highlights from the third quarter of 2023 and recent weeks include: |
ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New PatentsANN ARBOR, Mich., November 08, 2023--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces the issuance of three new patents, including one in the U.S. and two in China. ENDRA’s intellectual property (IP) portfolio now includes 70 issued patents worldwide, enhancing the IP protection for the novel TAEUS® system. |
NDRA Price Returns
| 1-mo | -76.70% |
| 3-mo | -77.98% |
| 6-mo | -76.30% |
| 1-year | -86.81% |
| 3-year | -99.45% |
| 5-year | -99.22% |
| YTD | -88.68% |
| 2023 | -47.91% |
| 2022 | -70.58% |
| 2021 | -7.76% |
| 2020 | -55.36% |
| 2019 | 12.00% |
Loading social stream, please wait...